SAFETY Rounds: Interim Financings After Term Sheet
How interim financings after a term sheet can reprice your deal before close, and how to protect your terms during the closing window.
Then payroll hits.
The company has $420,000 in the bank, burns $310,000 per month, owes a $190,000 annual insurance payment next week, and learns during confirmatory diligence that the new investor expects the company to have at least $750,000 of cash at closing after paying transaction expenses. The round is not closing for 24 days. Management has two options: cut hard and risk missing numbers during diligence, or raise a quick bridge to survive the gap.
So they do what many startups do. Existing investors wire in a $500,000 SAFE “just to get to close.” The founders call it temporary. The lead calls it practical. Company counsel calls it an interim financing.
Three weeks later, the Series A closes exactly where everyone thought it would: same headline valuation, same amount raised, same liquidation preference, same board. But the economics are not the same. The SAFE converted. Option pool math moved. Ownership shifted. The new lead negotiated tighter covenants and a larger option refresh because the company looked weaker. The old insiders got a discount and MFN protection. The “minimum cash at close” condition effectively forced the company to finance itself on the investor’s terms before the investor wired.
This is the trap.
Founders often think a signed term sheet locks the core economics of a priced round. It usually does not. Between signing and closing sits a dangerous zone where emergency SAFEs, insider notes, payroll bridges, and cash-balance fixes can quietly reprice the deal without ever changing the term sheet headline. I call this the “SAFETY” round trap: post-term-sheet money raised under the banner of safety, survival, or temporary bridge financing that transfers value to investors and reshapes the cap table before the main round closes.
The trap is common because the period between term sheet and close is exactly when a company is most exposed. The company has signaled weakness by needing capital. It has not yet received the institutional money. Diligence expands. Closing conditions harden. Lawyers discover issues. Customers pay slowly. Existing investors know the company has no leverage. New investors know the company cannot easily restart the fundraising process. Everyone understands that “temporary” money can become a tool to re-open economics indirectly.
The problem is not that interim financings exist. Sometimes they are rational and necessary. The problem is that founders routinely treat them as administrative instead of economic. They ask, “Can we get enough cash to make payroll?” when they should ask, “What exactly does this bridge do to pre-money ownership, liquidation stack, control, closing conditions, and negotiating leverage?”
If you do not model the answer, you are not bridging to close. You are renegotiating the round in slow motion.
The core problem: your term sheet may be signed, but your deal is not economically locked
A venture term sheet creates momentum, not certainty. Until definitive documents are signed and funds hit the bank, the round remains vulnerable to changes in:
Interim financings touch all of these.
Most priced-round term sheets are written assuming a fairly stable capitalization table from signing through closing. They usually reference a company capitalization schedule, a fully diluted ownership model, and a proposed investment amount at a stated pre-money or post-money valuation. But if the company raises money during the gap, especially money that converts at a discount or with a valuation cap, the cap table changes. Depending on the drafting, the burden of that change may fall disproportionately on founders and common holders, or it may alter the economics for everyone.
The issue becomes acute in four recurring situations:
In each case, someone offers “help.” Usually insiders. Sometimes the new lead. Sometimes both.
That help is rarely free.
Why current founder approaches fail
Founders usually make one of three mistakes.
1. They focus on amount raised, not instrument design
A founder hears: “We’ll put in $300,000 on a SAFE just to carry you to close.” The founder thinks in cash terms. Will this cover payroll? Rent? AWS? Good.
But the real question is: at what conversion mechanics, with what side rights, and against what capitalization definition?
A $300,000 SAFE converting into a $20 million pre-money Series A may sound immaterial. It is not always. If it has a discount, a cap below the round price, MFN rights, or side-letter information rights, it may create asymmetrical value transfer. If multiple bridges stack, the effect compounds.
2. They assume “same headline valuation” means same economics
This is the most dangerous misconception in venture finance.
A company can close exactly the same Series A at a $20 million pre-money valuation and still end up giving away meaningfully more ownership than the founders expected because:
The press release still says “raised $8 million at a $20 million pre.” The economic reality may look much closer to a lower effective price.
3. They treat interim money as separate from negotiation leverage
The bridge itself is not the only issue. The fact that the company needs it hands leverage to whoever can provide it or withhold consent.
Once the company demonstrates it cannot survive to close on existing cash, the lead investor can push for:
Founders often miss that the cash gap is a bargaining event. Not just a treasury event.
The core insight: interim financings are often an off-term-sheet repricing mechanism
When a company raises bridge capital between term sheet and close, the round’s economic bargain gets recalculated in at least four dimensions:
Even if the lead investor never asks to change the stated valuation, these four levers can produce a lower effective deal price.
The correct founder mindset is simple:
Any post-term-sheet financing should be modeled as if you are re-cutting the round economics from scratch.
Not just “what converts into what,” but:
If you do not re-forecast the whole cap table and liquidation structure, you are negotiating blind.
A practical baseline scenario
Let’s model a clean Series A before the trouble starts.
Initial capitalization before term sheet
Assume the company has:
Fully diluted pre-Series A share count: 10,000,000 shares
The company signs a Series A term sheet for:
Post-money shares: 14,000,000
Post-close ownership:
That is the model everyone uses in the board deck.
Now let’s introduce the bridge.
Scenario 1: the “tiny” emergency SAFE that is not tiny
The company needs $500,000 to cover payroll and satisfy a closing cash requirement. Existing insiders invest via SAFE after the term sheet is signed.
Terms:
Series A headline terms remain unchanged.
Conversion math
Series A price per share remains $2.00.
The SAFE converts at a 20% discount, so conversion price = $1.60.
SAFE shares issued on conversion: $500,000 / $1.60 = 312,500 shares
Now Series A post-close share count becomes:
Revised post-close ownership:
At first glance, 2.2% dilution does not look catastrophic. But look closer.
The insiders who put in only $500,000 got 2.2% of the company. At the stated $20 million pre-money, 2.2% of the post-close company is worth materially more than a purely pari passu same-price contribution would have yielded. The discount transferred value from existing common and prior holders to the bridge investors.
Effective valuation impact
If $500,000 had gone in at the Series A price of $2.00, the investors would have received 250,000 shares, not 312,500. The extra 62,500 shares are the hidden repricing.
At the Series A price, those extra shares represent $125,000 of incremental equity value transferred to bridge investors.
Said differently, the company did not merely borrow survival cash. It sold a slice of equity at a lower effective price while pretending the round price stayed fixed.
Scenario 2: the minimum-cash closing condition that forces founders to finance their own dilution
This one is more common than founders admit.
Suppose the term sheet says the Series A closes subject to customary conditions, including the company having at least $1.0 million of cash on hand at closing and no material adverse change. Sounds harmless.
But assume:
By the projected close date, the company would have:
$600,000 - $350,000 - $150,000 = $100,000
That means the company is short $900,000 relative to the minimum-cash closing condition.
So despite signing for an $8 million Series A, the company must first raise almost $1 million just to satisfy the buyer’s requirement that the target show up with cash.
This is economically absurd from the founder’s perspective but normal in venture practice when no one pushes back.
Why it matters
That $900,000 bridge often:
If this bridge converts at 20% discount into the same $2.00 round, it creates:
$900,000 / $1.60 = 562,500 shares
That is 3.8% of the post-close company in our example structure.
Again, the headline Series A valuation did not change. But the company effectively sold nearly 4% additional ownership to survive long enough to receive the institutional money.
The hidden second-order effect
Now imagine the lead investor sees the bridge and says: “Given tighter cash, we also need the option pool increased from 8% available post-close to 12% available post-close so you can hire a VP Engineering and Head of Sales.”
That option pool increase is often borne pre-money. Which means the founders, employees, and earlier holders absorb it before the new investor comes in.
If the pool needs to increase by 600,000 shares to satisfy the lead’s post-close target, then pre-money shares become 10,562,500 instead of 10,000,000, and the company may need to issue even more shares or adjust pricing mechanics depending on drafting.
Now the “minimum cash” fix has not only caused direct dilution through bridge conversion, but also induced a second repricing through pool expansion.
This is how a locked round drifts.
Scenario 3: insider bridge note with a cap lower than the term sheet valuation
Suppose instead of a discount SAFE, insiders offer a convertible note:
- $16 million pre-money cap
- 20% discount to Series A price
This is not a bridge. It is a miniature negotiation against a distressed borrower.
Assume the Series A closes 45 days later. Accrued interest is roughly $7,500, so total converting amount is $1,007,500.
At the signed Series A terms, the $20 million pre-money implies $2.00 per share based on the original 10,000,000-share model.
A 20% discount gives $1.60/share.
A $16 million cap on the same capitalization implies $1.60/share.
So conversion shares = $1,007,500 / $1.60 = 629,688 shares.
That alone is meaningful. But the bigger issue is legal leverage.
Because the note is secured and has a separate consent right, the insiders now have a blocking position over changes to the financing that affect their economics. If the lead later asks for modifications in definitive docs, the bridge investors may need to sign off. They can extract concessions. They can also threaten to remain outstanding if the closing slips.
Even if everything converts cleanly, the company has inserted a new stakeholder into the closing mechanics at exactly the worst time.
Scenario 4: the bridge raised from the incoming lead
Founders sometimes think taking the interim money from the lead investor is safer because interests are aligned. Sometimes yes. Often no.
If the lead provides a $750,000 pre-close SAFE or note, it may use that position to improve its economics in subtle ways:
For example, assume the lead agrees to invest $8 million in the Series A but first advances $750,000 on a 20% discount SAFE. At closing, the lead invests only another $7.25 million in cash because the $750,000 is credited toward its total commitment.
Economically, the lead has effectively received part of its allocation at $1.60/share and the balance at $2.00/share.
Shares from bridge portion: $750,000 / $1.60 = 468,750
Shares from remaining Series A cash: $7,250,000 / $2.00 = 3,625,000
Total lead shares: 4,093,750
If the entire $8 million had gone in at $2.00, the lead would receive 4,000,000 shares.
That extra 93,750 shares are hidden deal drift. Not massive in isolation, but real. And if the lead also insists on a larger option pool or revised governance because “the company needed support,” the aggregate repricing becomes material.
Consent mechanics: the clause founders ignore until it matters
Interim financings are not just math. They are consent architecture.
Before taking any bridge money after term sheet, founders need to map at least five approval layers:
A company may need approval to:
This matters because whoever holds a consent right has leverage during the gap.
A classic failure pattern looks like this:
The bridge that was supposed to simplify closing ends up complicating it.
The right move is to build a consent map immediately after signing the term sheet, not when payroll is three days away.
Cap table re-forecasting: what founders must model before accepting any interim money
If you only ask counsel for a redline and do not ask your CFO or finance lead for a full cap table re-forecast, you are making a category error.
At minimum, model four cases:
Case A: no bridge, close on schedule
This is your base case. Confirm expected ownership, cash delivered at close, and post-close runway.
Case B: bridge closes, priced round closes on same terms
Model:
Case C: bridge closes, priced round slips 30–45 days
Add:
Case D: bridge closes, lead investor economically re-trades via side adjustments
Model sensitivity if:
This is how founders discover that a “small” bridge can move ownership by 2%–6% and reduce net cash by more than expected.
Liquidation dynamics: the hidden cost beyond dilution
Dilution is the obvious issue. Liquidation economics are the subtler one.
Suppose the bridge is structured as debt and remains outstanding until the Series A closes. If the deal breaks and the company cannot raise elsewhere, those bridge holders may have:
If the bridge is from insiders, founders may shrug because “they’re friendly.” That is naive. Friendly capital becomes hard capital once downside enters the room.
Even if the bridge converts into preferred at closing, side terms can alter future outcomes:
A founder who optimizes only for getting to close may accidentally worsen downside outcomes if the company later sells for a middling amount.
For example, if $1 million of bridge debt with accrued interest becomes preferred shares at a favorable conversion price, those holders can end up with a larger portion of proceeds in a $30 million–$50 million exit than common expects, especially when layered with standard 1x liquidation preference for the Series A.
No, the bridge probably does not rewrite the entire preference stack. But it can materially shift who captures marginal proceeds.
Negotiation scenarios founders should expect
Scenario A: “We’re not changing valuation, we just need a top-up SAFE”
What to hear: “We are changing valuation indirectly.”
Response:
Scenario B: “We need minimum cash at close”
What to hear: “We want the company de-risked before we fund.”
Response:
This one point alone can save meaningful dilution.
Scenario C: “Insiders will bridge, but they need a discount because it’s rescue money”
What to hear: “We are monetizing your urgency.”
Response:
If the bridge truly exists only to reach a signed priced round, rescue pricing is often unjustified.
Scenario D: “The bridge is small, so the docs don’t matter”
What to hear: “No one has modeled the side rights.”
Response:
Small instruments create big headaches when a deal slips.
Practical founder tactics to prevent silent repricing
Here is the blunt version: the best way to survive the term-sheet-to-close gap is to plan never to be forced into a bridge during it.
That means starting fundraising with more runway than you think you need. But if you are already in the gap, use these tactics.
1. Negotiate closing-condition cash requirements at term sheet stage
Do not gloss over “minimum cash at close.” Ask:
Many founders accept a vague minimum-cash condition and only later realize it forced them into dilution.
2. Prefer advance subscriptions over discounted bridge paper
If the lead or insiders are willing to provide cash before close, the cleanest structure is often an advance payment toward the priced round at the same share price, subject to close mechanics. This is not always feasible legally, but economically it is usually better than a discounted SAFE or cap note.
The principle is simple: if everyone already agreed on pricing, temporary timing risk should not automatically justify repricing.
3. Make bridge economics symmetrical
If a bridge must be done, seek:
The bridge should solve time, not re-trade price.
4. Build a weekly close-model dashboard
During the gap, update weekly:
This sounds operational because it is. Most “surprise” bridges are only surprises because the company was not modeling the glide path to close.
5. Tighten the no-shop and exclusivity trade
If the lead wants exclusivity during diligence, and the company may need pre-close money, then tie those together. For example:
That is a fair trade. If the lead wants the deal locked, the lead should not benefit from starvation leverage.
6. Re-open the round amount before re-opening price
If the company needs an extra $1 million to reach safe runway, sometimes the right answer is not a separate bridge. It is to increase the size of the priced round itself.
Founders too often defend the headline valuation while accepting ugly bridge paper. Better to ask whether the lead will increase the round from $8 million to $9 million on the same price than to patch the gap with a discounted side instrument.
Yes, this may affect ownership. But it is often cleaner, more transparent, and less distortionary than a pre-close bridge.
7. Force a full economic comparison in board materials
Before approving any interim financing, present the board with side-by-side economics:
Include ownership, net cash, and liquidation impact. Once directors see the side-by-side math, it becomes harder for insiders to pretend a discounted emergency instrument is “just standard.”
A term sheet comparison founders should actually run
Let’s compare three ways to solve a $1 million pre-close shortfall in our baseline company.
Option 1: discounted SAFE
Conversion shares: 625,000
Total post-close shares: 14,625,000
Bridge ownership: 4.27%
Series A ownership: 27.35%
Founder ownership: 47.86%
Option 2: same-price advance into the round
Shares on advance: 500,000
Remaining Series A cash at close: $7,000,000 for 3,500,000 shares
Total new investor/advance shares: 4,000,000
If the same investor advances and then completes the round, the economics are identical to the original $8 million round. No hidden extra shares. This is the clean solution if the lead will agree.
Option 3: increase Series A size to $9,000,000
Series A ownership: 31.03%
Founder ownership: 48.28%
Notice the trade-offs.
Option 3 dilutes everyone because more capital is raised. But it is transparent and adds actual runway. Option 1 may look cheaper because the headline round size stays the same, but depending on who buys the SAFE and what side rights attach, it can be nearly as dilutive and much messier legally. Option 2 is often best if available.
The lesson: compare solutions based on full economics, not financing labels.
What investors will say, and when they are right
Investors are not always wrong here.
There are cases where bridge investors deserve compensation:
If someone is writing a check into genuine uncertainty, some price benefit may be justified.
But that is exactly why founders must distinguish between:
Those are different situations. Do not pay rescue pricing for scheduling risk.
The blunt takeaway
A signed term sheet does not mean your valuation is safe.
If you raise interim money between signing and closing, you should assume the deal is being economically renegotiated unless you prove otherwise with math and documents.
The bridge may be necessary. Fine. But treat it as a full-stack negotiation over price, dilution, liquidation, and leverage. Because that is what it is.
The founders who get trapped are the ones who say, “It’s only for a few weeks.”
A few weeks is enough to:
And all of that can happen while the headline valuation never changes by a dollar.
So the practical rule is simple.
Between term sheet and close, do not ask only whether the company can survive.
Ask whether the survival money changes the deal.
Because if it does, and you did not model it, your round was repriced before it ever closed.
RaiseSimpli Team
Author